Indeed, lung contribution to circulating osteopontin was clearly demonstrated previously by measuring the transpulmonary osteopontin gradient in heart failure patients [56] and there is clinical and experimental evidence of increased osteopontin expression in the lungs [41,57] as well as in the right ventricle [57]. This evidence concerns the gene SPP1 and heart failure.